Omeprazole Dosing for a 5-Year-Old Child
For a 5-year-old child with GERD or erosive esophagitis, administer omeprazole 10 mg once daily if the child weighs less than 20 kg, or 20 mg once daily if the child weighs 20 kg or more. 1
Weight-Based Dosing Algorithm
The FDA-approved dosing for pediatric patients aged 2-16 years is straightforward and weight-dependent 1:
- Child weighing <20 kg: 10 mg once daily
- Child weighing ≥20 kg: 20 mg once daily
Since most 5-year-olds weigh between 15-22 kg, you'll need to determine the child's actual weight to select the appropriate dose. The typical 5-year-old weighs approximately 18-20 kg, placing many at the threshold between these two dosing tiers.
Clinical Context and Dosing Range
While the FDA label provides clear weight-based dosing, the American Academy of Pediatrics guidelines indicate that the effective dosage range for omeprazole in children is 0.7-3.3 mg/kg/day 2. This broader range allows for dose titration in refractory cases, though most children respond to the lower end of this spectrum.
For a typical 5-year-old weighing 18 kg:
- 10 mg daily = 0.56 mg/kg/day (slightly below the guideline range but FDA-approved)
- 20 mg daily = 1.1 mg/kg/day (within the guideline range)
Research data supports that 0.7 mg/kg/day is an effective starting dose for most children, with the majority (44%) of children in clinical trials healing with this dose 3.
Administration Instructions
Give omeprazole before meals 1. The capsule should be swallowed whole, but if the child cannot swallow it intact:
- Place one tablespoon of applesauce in a clean container
- Open the capsule and empty all pellets onto the applesauce
- Mix the pellets with applesauce
- Have the child swallow immediately with cool water
- Do not chew or crush the pellets 1
The sprinkle formulation is specifically FDA-approved for children aged 2-16 years 2.
Treatment Duration
- Symptomatic GERD: Up to 4 weeks 1
- Erosive esophagitis: 4-8 weeks initially 1
- If no response after 8 weeks, consider an additional 4-week course 1
- Maintenance therapy: Can continue once daily, though controlled studies don't extend beyond 12 months 1
Important Clinical Caveats
Overuse concerns: The AAP guidelines specifically caution against overuse of PPIs in children, particularly noting that placebo-controlled trials in infants have not demonstrated superiority over placebo for reducing irritability 2. Ensure there is a clear indication (documented erosive esophagitis or symptomatic GERD) before initiating therapy.
Monitoring considerations:
- Elevated gastrin levels occur in most children on omeprazole (73% in one study) 4
- Mild transaminase elevations may occur 4
- Long-term use (>2.5 years) has been associated with enterochromaffin cell hyperplasia in up to 50% of children 2
Drug interactions: Omeprazole is a CYP2C19 inhibitor and can interact with clopidogrel, certain antiretrovirals, and other medications metabolized by this pathway 1.
When Standard Dosing Fails
If symptoms persist despite appropriate weight-based dosing, the dose can be titrated upward within the 0.7-3.3 mg/kg/day range 2. In clinical trials, 28% of children required 1.4 mg/kg/day for healing 3. However, dose escalation should be guided by objective measures (endoscopy, pH monitoring) rather than symptoms alone, as symptom improvement doesn't always correlate with mucosal healing 5.
The evidence strongly supports starting with FDA weight-based dosing rather than immediately calculating mg/kg doses, as this approach is simpler, well-validated, and effective for the majority of children.